UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
March 26, 2004
Advanced Nutraceuticals, Inc.
-----------------------------
(Exact Name of Registrant as Specified in its Charter)
Texas
--------------------------------------------
(State or Other Jurisdiction of Incorporation)
0-26362 76-0642336
----------------------- ------------------------------------
(Commission File Number) (I.R.S. Employer Identification No.)
106 South University Blvd. #14, Denver, Colorado 80209
------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(Registrant's telephone number, including area code) - (303) 722-4008
---------------------------------------------------------------------
- --------------------------------------------------------------------------------
INFORMATION TO BE INCLUDED IN THE REPORT
Item 9. Regulation FD Disclosure
The Company issued a news release on March 26, 2004, a copy of which is attached
hereto as Exhibit 99.1.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ADVANCED NUTRACEUTICALS, INC.
Dated: March 26, 2004 By: /s/ Jeffrey G. McGonegal
----------------------------------
Jeffrey G. McGonegal
Senior Vice President of Finance